Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling study
Shoya Iwanami, Keisuke Ejima, Kwang Su Kim, et al.
PLoS Medicine (2021) Vol. 18, Iss. 7, pp. e1003660-e1003660
Open Access | Times Cited: 53

Showing 26-50 of 53 citing articles:

Within‐host dynamics of SARS‐CoV‐2 infection: A systematic review and meta‐analysis
Zhanwei Du, Shuqi Wang, Yuan Bai, et al.
Transboundary and Emerging Diseases (2022) Vol. 69, Iss. 6, pp. 3964-3971
Open Access | Times Cited: 5
Temporal Pattern of the Emergence of a Mutant Virus Escaping Cross-Immunity and Stochastic Extinction Within a Host
Rena Hayashi, Yoh Iwasa
Bulletin of Mathematical Biology (2023) Vol. 85, Iss. 9
Open Access | Times Cited: 2
Escaping stochastic extinction of mutant virus: Temporal pattern of emergence of drug resistance within a host
Rena Hayashi, Shingo Iwami, Yoh Iwasa
Journal of Theoretical Biology (2022) Vol. 537, pp. 111029-111029
Open Access | Times Cited: 4
Modelling the effectiveness of antiviral treatment strategies to prevent household transmission of acute respiratory viruses
Hind Zaaraoui, Clarisse Schumer, Xavier Duval, et al.
PLoS Computational Biology (2024) Vol. 20, Iss. 12, pp. e1012573-e1012573
Open Access
Stratification of viral shedding patterns in saliva of COVID-19 patients
Hyeongki Park, Raiki Yoshimura, Shoya Iwanami, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
EFFECTS OF ANTIVIRAL THERAPEUTIC DRUGS FOR SARS-COV-2 ON TREATMENT OUTCOMES AND CLINICAL PARAMETERS
Abdul Bari, Atiqullah Sarwari, Mohammad Hassan, et al.
Eurasian Journal of Ecology (2024) Vol. 79, Iss. 2, pp. 136-146
Open Access
Modeling the Spread of Viral Infection in a Local Atmosphere Infected with the SARS-CoV-2 Virus: Constant Virion Concentration
И. В. Деревич, A. A. Panova
Mathematical Models and Computer Simulations (2024) Vol. 16, Iss. 5, pp. 698-710
Closed Access
Computation of Reverse Degrees of Some Antiviral Drugs Targeting COVID 19 with QSPR Analysis
Parvez Ali, Syed Ajaz, K Kirmani, et al.
Biointerface Research in Applied Chemistry (2022) Vol. 13, Iss. 1, pp. 66-66
Open Access | Times Cited: 2
Relationship between the inclusion/exclusion criteria and sample size in randomized controlled trials for SARS-CoV-2 entry inhibitors
Daiki Tatematsu, Marwa Akao, Hyeongki Park, et al.
Journal of Theoretical Biology (2022) Vol. 561, pp. 111403-111403
Open Access | Times Cited: 2
Safely return to schools and offices: early and frequent screening with high sensitivity antigen tests effectively identifies COVID-19 patients
Yong Dam Jeong, Keisuke Ejima, Kwang Su Kim, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2
Reszinate—A Phase 1/2 Randomized Clinical Trial of Zinc and Resveratrol Utilizing Home Patient-Obtained Nasal and Saliva Viral Sampling
Henry G. Kaplan, Kai Wang, Kimberly M. Reeves, et al.
Frontiers in Drug Discovery (2022) Vol. 2
Open Access | Times Cited: 1
COVID-19 or SARS-COV-2 Works Published and Presentations 2020-2021
J. Patrick Fitch
(2021)
Closed Access | Times Cited: 1
Detection of significant antiviral drug effects on COVID-19 using viral load and PCR-positive rate in randomized controlled trials
Marwa Akao, Joohyeon Woo, Shingo Iwami, et al.
Translational and Regulatory Sciences (2021) Vol. 3, Iss. 3, pp. 85-88
Open Access | Times Cited: 1
Peer Review #2 of "Development of a novel mathematical model that explains SARS-CoV-2 infection dynamics in Caco-2 cells (v0.2)"

(2023)
Open Access
Peer Review #2 of "Development of a novel mathematical model that explains SARS-CoV-2 infection dynamics in Caco-2 cells (v0.1)"

(2023)
Open Access
Peer Review #1 of "Development of a novel mathematical model that explains SARS-CoV-2 infection dynamics in Caco-2 cells (v0.2)"

(2023)
Open Access
Peer Review #1 of "Development of a novel mathematical model that explains SARS-CoV-2 infection dynamics in Caco-2 cells (v0.1)"

(2023)
Open Access
Isolation may select for earlier and higher peak viral load but shorter duration in SARS-CoV-2 evolution
Junya Sunagawa, Kwang Su Kim, Hyeongki Park, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Isolation may select for earlier and higher peak viral load but shorter duration in SARS-CoV-2 evolution
Junya Sunagawa, Kwang Su Kim, Hyeongki Park, et al.
Research Square (Research Square) (2023)
Open Access
Analysis of the risk and pre-emptive control of viral outbreaks accounting for within-host dynamics: SARS-CoV-2 antigen testing as a case study
William S. Hart, Hyeongki Park, Yong Dam Jeong, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Stochastic Model of Infection with the SARS–COV–2 Virus in a Small Group of Individuals Indoors
И. В. Деревич, A. A. Panova
Lecture notes in computer science (2023), pp. 499-513
Closed Access
Simulation of infection of a group of people during evacuation from a limited space in a panic
Igor V. Derevich, Анастасия Андреевна Панова
AIP conference proceedings (2023) Vol. 2872, pp. 050006-050006
Closed Access
МАТЕМАТИКА В МЕДИЦИНЕ
Ю.В. Василевский, В.Ю. Саламатова, А.А. Легкий, et al.
ICSP «NEW SCIENCE» eBooks (2023)
Open Access
GAMBARAN PENGGUNAAN ANTIVIRUS PADA PASIEN RAWAT INAP NON-ICU COVID-19 DI RSUD ULIN BANJARMASIN
Kamila Rosyida, Rahmiati Rahmiati, Hendra Wana Nur’amin, et al.
Homeostasis (2023) Vol. 6, Iss. 2, pp. 347-347
Open Access
Rethinking methods used to evaluate the effectiveness of therapeutics for COVID-19 and other viral respiratory illnesses
Jean‐François Rossignol
Future Virology (2022) Vol. 17, Iss. 2, pp. 67-69
Open Access

Scroll to top